← Back to Search

Optical Coherence Tomography

Retinal Imaging with Low-Cost OCT Device vs Commercial OCT Device for Optical Coherence Tomography

N/A
Waitlist Available
Led By Adam Wax, Ph.D.
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during study procedures (30 minutes)
Awards & highlights

Study Summary

This trial is testing a new OCT device to see if it takes images of the retina that are as good as a commercial device.

Who is the study for?
This clinical trial is for individuals who are able to understand and agree to the study's procedures by providing informed consent. There are no specific health conditions listed, so it may be open to a wide range of participants.Check my eligibility
What is being tested?
The trial is testing the effectiveness of a new low-cost optical coherence tomography (OCT) device compared to an existing commercial OCT device in producing quality retinal images.See study design
What are the potential side effects?
Since this trial involves non-invasive retinal imaging, there are typically no side effects associated with the procedure itself. However, discomfort from bright lights or sitting still during imaging might occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during study procedures (30 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during study procedures (30 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants with Acceptable OCT Image Quality as Measured by Low-Cost OCT Device
Secondary outcome measures
Contrast-to-Noise Ratio (CNR)

Trial Design

1Treatment groups
Experimental Treatment
Group I: OCT ImagingExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,057 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,102 Total Patients Enrolled
Adam Wax, Ph.D.Principal InvestigatorDuke University
5 Previous Clinical Trials
260 Total Patients Enrolled

Media Library

Low-cost OCT device (Optical Coherence Tomography) Clinical Trial Eligibility Overview. Trial Name: NCT05530460 — N/A
Optical Coherence Tomography Research Study Groups: OCT Imaging
Optical Coherence Tomography Clinical Trial 2023: Low-cost OCT device Highlights & Side Effects. Trial Name: NCT05530460 — N/A
Low-cost OCT device (Optical Coherence Tomography) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05530460 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there presently any capacity to join this investigation?

"As of now, this clinical trial is not actively enrolling patients. According to the data on clinicaltrials.gov, which was last edited on November 16th 2022, recruitment for this study has temporarily ceased; however, there are other trials presently searching for participants."

Answered by AI

Who is qualified to volunteer for this medical research program?

"This medical experiment is seeking 12 individuals aged between 18 and 85, who have a documented occurrence of retinal optical coherence tomography. Additionally, the participants must be able to provide valid informed consent."

Answered by AI

Is the age threshold for this research study less than 55?

"This research initiative is open to individuals over 18 and below 85 years of age."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Comparative Study of High Performance Low-Cost Optical Coherence Tomography
2024. "Comparative Study of High Performance Low-Cost Optical Coherence Tomography". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05530460.
~8 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top